CDSCO has mandated online submission of applications for licences to manufacture and sell r-DNA-origin drugs through the ONDLS portal ...

Researchers uncovered millions of ancient plant DNA switches—some older than flowering plants themselves—revealing a hidden evolutionary blueprint stretching back 400 million years. Most people have ...

CDSCO mandates application process for license of r-DNA products to be only through ONDLS portal: Gireesh Babu, New Delhi ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

Researchers simulated nearly every molecule in a bacterial cell — and then watched the cell grow and reproduce.

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

The Central Drugs Standard Control Organization (CDSCO) has announced that all applications related to Post Approval Changes (PAC) for recombinant DNA (r-DNA) products must now ...

CDSCO switches application procedure for PAC in marketing authorisation on r-DNA products online: Gireesh Babu, New Delhi Wednesday, March 11, 2026, 08:00 Hrs [IST] The Central Dr ...